While Ratti et al. [119] mentioned FGFR2 fusion as the most prevalent FGFR alteration in CC, they reported different predominant alterations for GC and HCC, namely FGFR4 mutations and FGFR3/4 amplifications, respectively. This evidence concerns the gene FGFR4 and cholangiocarcinoma.